This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact The Epoch Times Reprints.
A woman holds a small bottle labeled with a "Vaccine COVID-19" sticker and a medical syringe in this illustration taken on April 10, 2020. Dado Ruvic/Illustration/Reuters
CHICAGO—The U.S. government has awarded Novavax Inc $1.6 billion to cover testing, commercialization, and manufacturing of a potential coronavirus vaccine in the United States, with the aim of delivering 100 million doses by January 2021.
Novavax shares jumped 35 percent in premarket trade.
